Diebold Nixdorf Incorporated (DBD): Congress and insider trades
Who in Congress and inside the company traded DBD, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Diebold Nixdorf Incorporated (DBD) is a listed stock on NYSE.
- Insiders filed 5 open market buys worth $300K and 9 sells worth $79M, the latest filed 2026-07-31 (31 July 2026).
- 1 cluster buy of DBD by three or more insiders within 30 days.
- Across 3 scored buys, Insiders averaged -16.3% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell.
- Data as of 2026-09-29 (29 September 2026).
Insider trades in DBD
as of 2026-07-31| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 31 Jul 2026 | Timko Thomas S | buy | 700 | $72.29 | $50.6K | n/a |
| 30 Jun 2026 | Millstreet Capital Management | sell | 100,000 | $84.80 | $8.5M | n/a |
| 26 Jun 2026 | Millstreet Capital Management | sell | 2,741 | $85.06 | $233K | n/a |
| 26 Jun 2026 | Millstreet Capital Management | sell | 228,723 | $83.95 | $19M | n/a |
| 12 Jun 2026 | Millstreet Capital Management | sell | 17,660 | $82.08 | $1.4M | n/a |
| 12 Jun 2026 | Millstreet Capital Management | sell | 1,108 | $82.06 | $90.9K | n/a |
| 10 Jun 2026 | Millstreet Capital Management | sell | 88,334 | $82.99 | $7.3M | n/a |
| 27 May 2026 | Marquez Octavio | buy | 629 | $79.37 | $49.9K | -18.1% |
| 27 May 2026 | Marquez Octavio | buy | 621 | $79.56 | $49.4K | -18.1% |
| 22 May 2026 | Timko Thomas S | buy | 672 | $74.36 | $50.0K | -15.4% |
| 22 May 2026 | Myers Jonathan | buy | 1,360 | $73.41 | $99.8K | -15.4% |
| 17 Apr 2026 | Millstreet Capital Management | sell | 51,472 | $85.43 | $4.4M | n/a |
| 17 Apr 2026 | Millstreet Capital Management | sell | 60,833 | $84.77 | $5.2M | n/a |
| 10 Apr 2026 | Millstreet Capital Management | sell | 399,929 | $82.42 | $33M | n/a |
Nothing matches that search.
Cluster buys in DBD
| Last filed | Stock | Insiders | Trades | Total value | Days spanned | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 27 May 2026 | DBD | 3 | 4 | $249K | 5 | -18.1% |
Related pages
Frequently asked questions
Who has bought DBD?
0 Congress buys by 0 members and 5 insider buys are on file. The tables on this page list every one.
Did buying DBD after a disclosure beat the market?
Across 3 scored buys, Insiders averaged -16.3% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.